Suppliers / Biochem Sioux City

Biochem Sioux City

United States Updated 9 July 2026

Biochem Sioux City is an API manufacturer based in United States. It holds one active US drug master file. Its most recent recorded inspection, by US FDA, closed on 6 August 2021 as VAI.

1
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 6 August 2021 VAI US FDA
  • 2 November 2011 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Sioux City, United States 1910218

What they file, and where

Molecule Regulators Docs
Heparin Sodium US FDA 1

Also appears on these molecule pages

Heparin API

Questions about Biochem Sioux City

Does Biochem Sioux City hold a US DMF or a CEP?
Biochem Sioux City holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Biochem Sioux City FDA-registered?
One site operated by Biochem Sioux City carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Biochem Sioux City's last inspection go?
The most recent inspection on record closed on 6 August 2021 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 2 inspections are on file.
Where does Biochem Sioux City manufacture?
1 registered site is on record, in United States (Sioux City). Every site is listed on this page with the register it came from.
What does Biochem Sioux City make?
1 molecule is on record against Biochem Sioux City, including Heparin Sodium. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Biochem Sioux City comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 6 August 2021.

Comparable suppliers

Gland Pharma shares 1 molecule Sandoz shares 1 molecule Leo Pharma shares 1 molecule Dongying Tiandong Pharmaceutical shares 1 molecule Hebei Changshan Biochemical Pharmaceutical shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability